Correction: Triglyceride-glucose index and subclinical left ventricular dysfunction across cardiovascular-kidney-metabolic syndrome stages: a 7-year retrospective cohort study - Scorecard - MDSpire

Correction: Triglyceride-glucose index and subclinical left ventricular dysfunction across cardiovascular-kidney-metabolic syndrome stages: a 7-year retrospective cohort study

  • By

  • Kun-Zhe Tsai

  • Gen-Min Lin

  • Chunho Yun

  • Kuotzu Sung

  • Charles Jia-Yin Hou

  • Hung-I Yeh

  • Nguyen Ngoc Khoi Truong

  • Chung-Lieh Hung

  • July 13, 2026

Share

Clinical Scorecard: Correction: The Relationship Between Triglyceride-Glucose Index and Subclinical Left Ventricular Dysfunction in Various Stages of Cardiovascular-Kidney-Metabolic Syndrome: Findings from a 7-Year Retrospective Cohort Analysis

At a Glance

CategoryDetail
ConditionCardiovascular-Kidney-Metabolic Syndrome
Key MechanismsTriglyceride-glucose index and left ventricular dysfunction
Target PopulationPatients with cardiovascular-kidney-metabolic syndrome
Care SettingRetrospective cohort study

Key Highlights

  • Correction of ethics approval number
  • Study focuses on triglyceride-glucose index
  • Investigates subclinical left ventricular dysfunction
  • Covers various stages of cardiovascular-kidney-metabolic syndrome
  • Based on a 7-year retrospective cohort analysis

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Not specified in the correction

          Not specified in the correction

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Correction: Triglyceride-glucose index and subclinical left ventricular dysfunction across cardiovascular-kidney-metabolic syndrome stages: a 7-year retrospective cohort study

            • by Kun-Zhe Tsai, Gen-Min Lin, Chunho Yun, Kuotzu Sung, Charles Jia-Yin Hou, Hung-I Yeh, Nguyen Ngoc Khoi Truong, Chung-Lieh Hung

            • July 13, 2026

            Related Content

            A multi-center, open-label, observational study to evaluate the efficacy and safety of LivaloZet® tablets in patients with dyslipidemia and metabolic syndrome: PIVOT study protocol

            Mechanistic study of ARHGAP27 promoting the progression of aortic dissection by regulating the RhoA/ROCK/YAP pathway

            Hemodynamic effects of finerenone on blood pressure and heart rate in hospitalized patients with type 2 diabetes: a real-world study